| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8439575 | European Journal of Cancer | 2018 | 11 Pages |
Abstract
This is the largest study to date indicating that EBV and MMRdef do not play a role in OeC carcinogenesis in contrast to GC. The potential clinical usefulness of determining MMRdef/EBV status to screen patients for eligibility for immune-targeting therapy differs between OeC and GC patients.
Keywords
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
L.C. Hewitt, I.Z. Inam, Y. Saito, T. Yoshikawa, A. Quaas, A. Hoelscher, E. Bollschweiler, G.E. Fazzi, V. Melotte, R.E. Langley, M. Nankivell, D. Cunningham, W. Allum, G.G. Hutchins, H.I. Grabsch,